| Authors: |
Chen W; Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijingk, China., Cai Z; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China., Chim CS; Department of Medicine, Hong Kong Sanatorium Hospital, Hong Kong., Chng WJ; National University Cancer Institute, Singapore., Du J; Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Fu C; The First Affiliated Hospital of Soochow University, Jiangsu, China., Gao W; Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China., Hanamura I; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Aichi, Japan., Hou J; Department of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China., Huang JS; National Taiwan University Hospital, Taiwan., Ishida T; Japanese Red Cross Medical Center, Tokyo, Japan., Li C; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China., Liu A; Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China., Ptushkin V; Botkin Moscow City Clinical Hospital, Russia., Takezako N; Nerima Hikarigaoka Hospital, Tokyo, Japan., Wong RSM; Sir Y.K. Pao Centre for Cancer & Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong., Yoon DH; University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea. |
